Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Retinal-Angio Findings in Patients With Diabetes Type II Treated With Novel Antidiabetic Therapies

NCT07602348 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT07602348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07602348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Retinal-Angio Findings in Patients With Diabetes Type II Treated With Novel Antidiabetic Therapies
Lead sponsor
University of Athens
Phase
Observational
Overall status
Active, not recruiting
Start date
March 1, 2024
Completion date
May 31, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy, endothelial dysfunction, glp-1, microvascular circulation, retinal vascular diseases, sglt 2 inhibitors